Desoximetasone is a topical steroid indicated for corticosteroid-responsive dermatoses. Topical corticosteroids share anti-inflammatory, anti-pruritic, and vasoconstrictive actions. They play a role in cellular signaling, immune function, inflammation and protein regulation.
Desoximetasone will be available as a 0.25% strength ointment in 15g, 60g, and 100g tubes. It is expected to launch in the second quarter of 2016.
For more information call (856) 697-1441 or visit Teligent.com.